Morgan Cantley, PharmD, BCOP
Advertisement
Articles by Morgan Cantley, PharmD, BCOP
Morgan Cantley, PharmD, BCOP, shares key insights about the HER2-targeting antibody-drug conjugate trastuzumab deruxtecan.
Advertisement
Latest Updated Articles
Trastuzumab and HER2-Targeted Therapy: Breaking Down the BasicsPublished: August 15th 2025 | Updated:
- Expert Highlights Advances in HER2-Directed Therapies Beyond HER2-Positive Disease
Published: August 18th 2025 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Denosumab Biosimilars, Osvyrti and Jubereq, for Reference Products’ Indications
2
CDC’s Autism Statement Sparks New Concerns Over Vaccine Safety Messaging
3
Patients With Long COVID Face Varying Trajectories, With Most Facing Symptoms Long After Infection
4
Weight Loss Drugs On the Horizon: What Pharmacists Should Know
5
